CalciMedica Receives FDA Clearance to Continue Auxora KOURAGE Trial
LA JOLLA, Calif., June 24, 2026 CalciMedica, Inc. announced that the U.S. Food and Drug Administration (FDA) has completed...
inflammatory diseases
Advertisement
MoonLake Reports Strong Phase 3 Sonelokimab HS Results
ZUG, Switzerland, June 21, 2026 MoonLake Immunotherapeutics has announced compelling Week 52 results from its Phase 3 VELA clinical...
GSK and Spero Secure FDA Nod for First Oral Carbapenem
LONDON, United Kingdom, June 18, 2026 GSK plc and Spero Therapeutics have achieved a major milestone in the fight...
Biogen Signs Landmark RayThera Acquisition Worth Up to $1 Billion
CAMBRIDGE, Mass. and SAN DIEGO, June 17, 2026 Biogen Inc. has announced a strategic agreement to acquire RayThera Inc....
Resolution Therapeutics Expands Regenerative Macrophage Therapy with In Vivo Platform
EDINBURGH & LONDON, UK, June 17, 2026 Resolution Therapeutics announced the expansion of its pipeline for inflammatory and fibrotic...
Advertisements
Bristol Myers Squibb Declares Quarterly Dividend Payment
PRINCETON, N.J., June 17, 2026 Bristol Myers Squibb (BMS) has announced that its Board of Directors has declared a...
Triveni Bio Secures $65M to Advance TRIV-573 Development
WATERTOWN, Mass., June 17, 2026 Triveni Bio, a clinical-stage biotechnology company developing innovative antibody therapies for immunological and inflammatory...
Bambusa Therapeutics Reports Positive Phase 1 BBT002 Data at EAACI 2026
BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...
Kelun-Biotech and Windward Bio Advance SKB378 in COPD
CHENGDU, China – June 9, 2026 Kelun-Biotech has announced that its partner Windward Bio has successfully dosed the first...
Shattuck Labs to Present Phase 1 Data for SL-325 on June 8
AUSTIN, Texas and DURHAM, N.C., June 5, 2026 Shattuck Labs announced that it will host an investor call and...
Advertisement
